Effect of antioxidants on semen parameters in men with oligo‐astheno‐teratozoospermia: a network meta‐analysis
Andrology · 2024
DOI: 10.1111/andr.13498 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Andrology, 2024. Verfasst von Arcangelo Barbonetti und 11 weiteren Autor:innen. Beteiligte Einrichtung: Andrology Unit, Department of Clinical Medicine, Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy. Hauptthemen laut MEDLINE: Antioxidants, Asthenozoospermia. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 93 Literaturangaben.
Abstract (Originalsprache)
Background
Although antioxidants are largely used in subfertile men with oligo‐astheno‐teratozoospermia (OAT), the choice among different molecules is challenged by the lack of comparative head‐to‐head studies. The network meta‐analysis (NMA) can overcome limitations of pairwise meta‐analyses, since it incorporates direct and indirect evidence into a single model generating an effectiveness hierarchy.
Objective
To assess with a NMA the effects of antioxidants in improving seminal parameters in idiopathic OAT. Materials and methods PubMed, Scopus, Cinahl, and Cochrane Library databases were searched for randomized controlled trials (RCTs) comparing any antioxidant treatment to each other or placebo in men with at least one idiopathic seminal abnormality. Data were included in a random‐effects NMA, where efficacy of treatments was ranked by surface under the cumulative ranking curve (SUCRA).
Results
29 RCTs provided information on 2045 men (mean age: 33.5 years) with idiopathic OAT and 19 antioxidant preparations. Compared to placebo, l ‐carnitine, especially in combination with l ‐acetyl‐carnitine (LAC), had the highest SUCRA for sperm concentration, progressive motility, and morphology. Folate was the only other compound effective on sperm concentration. Vitamin E+selenium or zinc had the highest SUCRA for total motility. A contribution on progressive motility was revealed for pentoxifylline and vitamin E+CoQ10.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Andrology Unit, Department of Clinical Medicine, Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
- Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
- Endocrinology, Diabetology and Andrology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.
- Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Unità di Andrologia e Medicina della Riproduzione Sessuale Maschile e Femminile, Università Federico II di…
- UNESCO Chair for Health Education and Sustainable Development, Università Federico II di Napoli, Naples, Italy.
- Department of Experimental Medicine, Sapienza University of Rome, Policlinico Umberto I Hospital, Rome, Italy.
ORCID-Profile: Arcangelo Barbonetti, Rosario Pivonello, Andrea M Isidori, Giovanni Corona
Zitieren
APA
Barbonetti, A., Tienforti, D., Castellini, C., Giulio, F. D., Muselli, M., Pizzocaro, A., Vena, W., Baroni, M. G., Pivonello, R., Isidori, A. M., Maggi, M., & Corona, G. (2024). Effect of antioxidants on semen parameters in men with oligo‐astheno‐teratozoospermia: a network meta‐analysis. Andrology. https://doi.org/10.1111/andr.13498
Vancouver
Barbonetti A, Tienforti D, Castellini C, Giulio FD, Muselli M, Pizzocaro A, et al. Effect of antioxidants on semen parameters in men with oligo‐astheno‐teratozoospermia: a network meta‐analysis. Andrology. 2024. doi:10.1111/andr.13498
BibTeX
@article{Barbonetti2024,
author = {Barbonetti, Arcangelo and Tienforti, Daniele and Castellini, Chiara and Giulio, Francesca Di and Muselli, Mario and Pizzocaro, Alessandro and Vena, Walter and Baroni, Marco Giorgio and Pivonello, Rosario and Isidori, Andrea M and Maggi, Mario and Corona, Giovanni},
title = {Effect of antioxidants on semen parameters in men with oligo‐astheno‐teratozoospermia: a network meta‐analysis},
journal = {Andrology},
year = {2024},
doi = {10.1111/andr.13498}
}
EUVIMED